Advertisement

Topics

Companies Related to "RNAs Play Role Protein Aggregation Neurodegenerative Disease" [Most Relevant Company Matches] RSS

21:31 EDT 18th March 2019 | BioPortfolio

Here are the most relevant search results for "RNAs Play Role Protein Aggregation Neurodegenerative Disease" found in our extensive corporate database of over 50,000 company records.

Showing "RNAs Play Role Protein Aggregation Neurodegenerative Disease" Companies 1–25 of 3,900+

Relevant

Proteostasis Therapeutics

Proteostasis Therapeutics is discovering “Proteostasis Regulators” (PRs), small molecule drugs that restore proper protein function to treat neurodegenerative, metabolic, genetic and inflammatory disorders. The Proteostasis Network (PN) is the cellular machinery responsible for protein folding, trafficking and clearance, and it can become imbalanced ...


Yumanity Therapeutics

Yumanity Therapeutics is transforming drug discovery for neurodegenerative diseases caused by protein misfolding. Formed in 2014 by renowned biotech industry leader, Tony Coles, M.D., and protein folding science pioneer, Susan Lindquist, Ph.D., the company is initially focused on discovering disease-modifying therapies for patients with Alzheimer’s di...

Proteostasis Therapeutics and Elan Corporation

Proteostasis Therapeutics is developing “Proteostasis Regulators” (PRs), small molecule drugs that restore proper protein function or remove misfolded and aggregated proteins to treat neurodegenerative, metabolic, genetic and inflammatory disorders. The Proteostasis Network is the cellular machinery responsible for protein folding, trafficking and ...


Neurome, Inc

Neurome, Inc. is a discovery stage biotechnology company that seeks therapeutic solutions to human neurodegenerative diseases. The company focuses its efforts on Alzheimer's disease, Parkinson's disease, Huntington's disease, and Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's disease) - usually fatal neurodegenerative disorders that are currently untreatable and share characteristics which mak...

Alzheon Inc.

Alzheon, Inc. is committed to developing innovative medicines for patients suffering from Alzheimer’s disease and other neurological and psychiatric disorders. Our lead clinical candidate, ALZ-801, is a first-in-class, oral inhibitor of amyloid aggregation and neurotoxicity - hallmarks of Alzheimer’s disease. ALZ-801 is an optimized, novel prodru...

Proximagen Neuroscience plc

Proximagen Neuroscience plc is a publicly traded neuroscience research company focused on drug development for neurodegenerative disorders, including Parkinson's disease and Alzheimer's disease. Proximagen is building a compound pipeline to address the significant unmet medical needs of patients with neurodegenerative disease through its own discovery programme for novel, low risk therapeutic can...

Context Therapeutics

Context Therapeutics is a private, Philadelphia, PA-based biotechnology company dedicated to creating new medicines to treat Sigma1-associated diseases. The company leverages breakthrough science on the biochemistry of Sigma1 protein, the role of Sigma1 in regulating client protein homeostasis, and the role of Sigma1 in disease to develop novel drugs targe...

Progenra, Inc.

Founded in 2002, Progenra is committed to discovering and developing high value medicines based on ubiquitin and ubiquitin-like protein pathways. Its early stage product portfolio addresses major unmet medical needs in cancer, inflammation, metabolic diseases, pathogen infection, muscle wasting, and neurodegenerative disease. Progenra is utilizing its worl...

ProMining Therapeutics Ltd

ProMining Therapeutics, Ltd., based in Israel, is an early-stage biopharmaceutical research and development company engaged in the discovery and development of novel oral, small-molecule drugs for a variety of indications including: cancer, inflammation, chronic pain, cardiovascular and viral diseases. The Company has developed CavitIIRx, a proprietary drug discovery and development platform, fo...

United Neuroscience, Inc.

United Neuroscience (UNS) is a clinical-stage biotech company dedicated to the development of first-in-class, disease-modifying therapeutics for Alzheimer’s disease and other neurodegenerative disorders. UNS was founded to address the social and economic burden of neurodegenerative proteinopathies and seeks to rapidly advance candidates into and through ...

Annexon Bioscience

Annexon is pioneering the development of classical complement pathway inhibitors for the treatment of neurodegenerative and autoimmune diseases. While the role of the pathway in autoimmunity has been known for some time, the Company’s breakthrough research has unveiled that the pathway is activated as the aging brain encounters stress or disease to co...

Proteostasis Therapeutics, Inc.

Proteostasis Therapeutics (PTI) is developing novel disease-modifying therapeutics that target the cellular pathways regulating protein folding, trafficking, and clearance. The Proteostasis Network (PN) is comprised of these interconnected cellular pathways and can become imbalanced by the cumulative effects of aging, disease, genetics and environmental fa...

CuraGen

CuraGen Corporation (Nasdaq: CRGN) is a biopharmaceutical company dedicated to improving the lives of patients by developing novel pharmaceutical products that address unmet medical needs. CuraGen’s deep understanding of the human genome has enabled us to gain greater insight into the molecular basis of disease. The Company's therapeutics are based on novel drug targets that are believed to pl...

Power3 Medical Products, Inc

Originally formed as a medical device company, Power3 Medical Products, Inc. has since transitioned to an innovative holding company strategically positioned to acquire specialty healthcare and biotechnology assets. On May 18, 2004, Power3 purchased the assets and intellectual properties of ProteEx of The Woodlands, TX. The company was founded in 2000 by two seasoned medical biotechnology veterans...

GameTime

Enriching Childhood Through Play for almost 80 years, GameTime is the leading brand of commercial play equipment in the world. GameTime works with childhood development experts in a research based design approach to create the most beneficial play environments available! With exciting programs and curricula, GameTime takes play to the next level, as they add value, education, fitness and fun t...

Keryx Biopharmaceuticals

Keryx Biopharmaceuticals Incorporated is a drug discovery and development company, that applies KinAce, its proprietary rational drug discovery technology, to genomics data in order to build a rich pipeline of drug candidates targeting protein kinases. Kinases, which play a key role in the way cells communicate, are implicated in a wide range of diseases.

KAI Pharmaceuticals, Inc.

KAI Pharmaceuticals is a biology-based product-driven pharmaceutical company developing a new class of therapeutics targeting cell-signaling enzymes that affect numerous disease pathways. The company is leveraging its leadership position in protein kinase C (PKC), an important and validated family of kinases, to rapidly advance product candidates into human clinical trials.KAI is developing therap...

BioAxone Therapeutic Inc.

BioAxone’s strategy is to become the world’s dominant bio-pharmaceutical company targeting Rho and Rho-related pathways with the purpose of developing drugs that meet large unmet medical needs. Rho being a signaling pathway which plays a key role in many disease indications, BioAxone has successfully developed a protein based inhibitor for local acute administration, as well as a family of sma...

miRagen Therapeutics, Inc.

Cardiovascular disease is the leading cause of death globally. Astonishingly, in the United States, every 37 seconds a person dies from cardiovascular disease. For survivors, life changes dramatically after an adverse heart event. Because of the significant toll that cardiovascular and muscle disease takes on patients, miRagen Therapeutics, Inc., was found...

Lotus Tissue Repair, Inc.

Lotus Tissue Repair, Inc. is developing its proprietary recombinant collagen type VII (rC7) technology as a treatment for dermatologic conditions in which rC7 may play an important role in accelerating chronic wound healing, such as diabetic foot ulcers, venous stasis ulcers and similar conditions. The company’s lead program is the first and only prot...

Key Drug Prototyping BV

KeyDP was founded in November 2001 by Flip Hoedemaeker, Jan Pieter Abrahams and Hans van Beek. Since our inception, we have been a private, independent income generating company. Our team believes in the power of establishing the 3 D structure of disease implied protein targets as the basis for rational drug design. We apply our high throughput protein crystallography technology as services to the...

AlphaVax, Inc

AlphaVax is developing a new vaccine technology with broad applications against infectious disease, cancer and biodefense threats which has the potential to redefine vaccines and the role they play in medicine. AlphaVax uses a specialized viral vector system to make alphavirus replicon vaccines called alphavaccines, which have shown excellent protection in multiple models for infectious disease an...

Protein Labs, Inc.

ProteinLabs is committed to playing an important role in the advancement of science by making our highly specialized expetise in protein purifications available to all scientists whose work involves protien purifications

Solace Pharmaceuticals

Solace Pharmaceuticals discovers and develops innovative treatments for pain. Solace's research and development programs are focused on exploiting novel biological understanding of disease targets that play a role in the pathogenesis of pain and that have disease-modifying potential in two key areas: modulating the activity of glial cells and intervening in the tetrohydrobiopterin (BH4) pathway. ...

Proteome Systems Limited

Proteome Systems Limited is an Australian based biotechnology company which discovers and develops diagnostic and therapeutic products. The Company has extensive expertise in the discovery and development of protein biomarkers. Our focus is on areas where there are large global markets and unmet need for diagnostics and drugs such as respiratory disease, neurodegenerative disease, cancer and infec...


More From BioPortfolio on "RNAs Play Role Protein Aggregation Neurodegenerative Disease"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks